AGN News and Press, Allergan plc From 10/24/19

DUBLIN , Oct. 24, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) approved the company's supplemental Biologics License Application (sBLA) for BOTOX ® for the treatment of pediatric patients (2 to 17 years of age) w...

DUBLIN , Oct. 23, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that its data will be featured during the 2019 American Society for Dermatologic Surgery Annual Meeting in Chicago, IL October 24-27 2019 . The meeting will be held at the Hyatt Regency Chicag...

Quick Take Oyster Point Pharma ( OYST ) intends to raise $85 million in an IPO of its common stock, according to an S-1/A registration statement . The company is advancing drug treatments for certain eye conditions. OYST has a potential upside catalyst in mid-2020 and the IPO appears re...

Annaly Capital Management ( NLY +1.6% ) took a bump up in afternoon trading after Bill Gross said he's  buying the stock as it appears the 2s-10s yield spread will widen. More news on: NVR, Inc., Annaly Capital Management, Inc., Invesco Ltd., Financial stocks news, Earnings news an...

DUBLIN , Oct. 17, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced it will release third quarter 2019 financial results on Tuesday, November 5, 2019 , prior to the open of U.S. financial markets. For additional materials related to Allergan's third quarter results, ...

Long-term dividend investors in the pharmaceutical sector have had quite a few high-quality stocks to invest in. One of these, however, seems to have fallen a little out of favor recently. Pharmaceutical giant AbbVie (NYSE: ABBV) has seen its shares fall significantly following news that i...

Hisamitsu Pharmaceutical Co. ( OTCPK:HTSUF ) subsidiary Noven Pharmaceuticals announces the FDA nod for SECUADO (asenapine) transdermal patch for the treatment of adults with schizophrenia. More news on: Hisamitsu Pharmaceutical Co., Inc., Allergan plc, Merck & Co., Inc., Healthcare ...

Merger activity decreased last week, with one new deal announced and seven deals closing. Deal Statistics: New Deals: The acquisition of Ra Pharmaceuticals ([[RARX]]) by UCB for $2.1 billion, or $48.00 per share in cash. Deal Updates: On October 8, 2019, Prosperity Bancs...

Quick Take 89bio ( ETNB ) has filed to raise gross proceeds of $70 million from a U.S. IPO, according to an S-1 registration statement . The firm is focused on developing and commercializing treatments for liver and cardio-metabolic diseases. ETNB plans to start Phase 2 trials in 2020 a...

DUBLIN , Oct. 14, 2019 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION Allergan plc (NYSE: AGN) (the " ...